Author:
Oliveira Cristiane,Lourenço Gustavo Jacob,Rinck-Junior José Augusto,de Moraes Aparecida Machado,Lima Carmen Silvia Passos
Funder
Fundação de Amparo à Pesquisa do Estado de São Paulo
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference48 articles.
1. Plati J, Bucur O, Khosravi-Far R. Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb). 2011;3(4):279–96.
2. Matin RN, Chikh A, Chong SL, Mesher D, Graf M, Sanza P, et al. P63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis. J Exp Med. 2013;210(3):581–603.
3. Poremba C, Yandell DW, Metze D, Kamanabrou D, Böcker W, Dockhorn-Dworniczak B. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression. Oncol Res. 1995;7(7–8):331–9.
4. Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1):a001008.
5. Michael D, Oren M. The p53-MDM2 module and the ubiquitin system. Semin Cancer Biol. 2003;13(1):49–58.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献